This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 08/10/2022
Location: Virtual
Subject: Listening Session on Considerations for Immunocompromised Patients
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Transplant Recipients and Immunocompromised Patient Advocacy Group

Event Date: 08/10/2022
Location: Virtual
Subject: Monkeypox Vaccine
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several groups of health care professionals

Event Date: 08/11/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: TRISTAN COLONIUS; PERHAM GORJI; MARK RAZA; PHILIPA FRIEDMAN; FRANK YIANNAS; REBECCA BUCKNER;
Non FDA Participant/Group: Daniel Salvadori, Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 08/11/2022
Location: Virtual
Subject: Treatment of Monkeypox
FDA Participant/Group: HILARY MARSTON; ADAM SHERWAT; LINDSAY TOBIAS; EMILY HELMS WILLIAMS;
Non FDA Participant/Group: Dana Mazo, Ken Raske, Michael Philips, Zeynep Sumer (Members of the Greater New York Hospital Association);

Event Date: 08/12/2022
Location: Virtual
Subject: Monkeypox Vaccine
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several groups of patient advocate and public health organizations

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/09/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several leaders from industry to include trade associations and manufacturers

Event Date: 08/12/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: TRISTAN COLONIUS; LARRY MORRIS;
Non FDA Participant/Group: Several staff from the Target Corporation

Event Date: 08/12/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: TRISTAN COLONIUS;
Non FDA Participant/Group: Several staff from the Rite Aid Corporation

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 08/09/2022
Location: Virtual
Subject: European Medicines Agency Work in Africa with Capacity Building and Multilateral Organizations
FDA Participant/Group: KRISTAN CALLAHAN, ANNA FERUS, SEMA HASHEMI, DOUGLAS SHAFFER
Non FDA Participant/Group: Martin Harvey, Victoria Palmi (European Medicines Agency);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 08/09/2022
Location: Virtual
Subject: Infant Formula Stakeholders Call
FDA Participant/Group: JOSEPH TOERNER; CHRISTINE BINA; CLAUDINE KAVANAUGH; ANDREA LOTZE; JENNIFER DOOREN; VALERIE JENSEN; EMILY THAKUR;
Non FDA Participant/Group: Allison Blackmer , Jay Mirtallo, Pat Anthony, Wanda Johnson (American Society for Parenteral and Enteral Nutrition (ASPEN));

Event Date: 08/09/2022
Location: Teleconference
Subject: Front Package Nutrition Labeling
FDA Participant/Group: N/A
Non FDA Participant/Group: Peter Lurie (Center for Science in the Public Interest);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 08/11/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: JASON LANCASTER;
Non FDA Participant/Group: Dennis Hall (United States Pharmacopoeia);

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event